Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$5.65B
sum of reported positions
Reported positions
543
Changes vs prior quarter
567
60 new · 52 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 344 measured positions in 8 quarters, the typical new or larger position finished −1.0 pts against the S&P 500 and 48% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 592K | $72.4M | 1.3% | |
| 109K | $62.8M | 1.1% | |
| 652K | $62.7M | 1.1% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $4.72B | $5.65B |
| Positions | 535 | 543 |
| Biggest line | — | Mercury Systems 1% |
| 848K |
| $62.4M |
| 1.1% |
| 565K | $55M | 1.0% |
| 690K | $48M | 0.8% |
| 659K | $47.7M | 0.8% |
| 1.58M | $47.2M | 0.8% |
| 611K | $46.4M | 0.8% |
| 1.63M | $45.7M | 0.8% |
| 149K | $44.2M | 0.8% |
| 545K | $42.7M | 0.8% |
| 112K | $42.4M | 0.7% |
| 426K | $41.5M | 0.7% |
| 172K | $40.1M | 0.7% |
| 357K | $40.1M | 0.7% |
| 234K | $37.6M | 0.7% |
| 540K | $37.6M | 0.7% |
| 227K | $37.3M | 0.7% |
| 601K | $36.8M | 0.7% |
| 230K | $35.7M | 0.6% |
| 345K | $34.4M | 0.6% |
| 660K | $34.4M | 0.6% |
| 670K | $34.3M | 0.6% |
| 479K | $33.4M | 0.6% |
Powell Industries, Inc. (POWL)
9,211 → 25K shares (+176%)
Jazz Pharmaceuticals (JAZZ)
18K → 30K shares (+69%)
Insmed (INSM)
35K → 56K shares (+62%)
Boston Scientific (BSX)
62K → 139K shares (+122%)
Roivant Sciences (ROIV)
122K → 164K shares (+34%)
Agilent Technologies (A)
41K → 43K shares (+4%)
Astrazeneca (AZN)
29K → 30K shares (+3%)
Conduent (CNDT)
1.82M → 3.85M shares (+112%)
Design Therapeutics (DSGN)
272K → 384K shares (+41%)
Roper Technologies (ROP)
7,706 → 15K shares (+99%)
Chemed Corp. (CHE)
9,420 → 11K shares (+18%)
Highpeak Energy (HPK)
119K → 735K shares (+518%)
Candel Therapeutics (CADL)
93K → 488K shares (+427%)
Waystar Holding Corp (WAY)
217K → 239K shares (+10%)
Arvinas (ARVN)
553K → 589K shares (+7%)
Unity Bancorp Inc (UNTY)
80K → 82K shares (+3%)
Argenx (ARGX)
4,577 → 4,698 shares (+3%)
Incyte (INCY)
36K → 38K shares (+3%)
ishares Trust
4,537 → 21K shares (+356%)
Tennant Company (TNC)
37K → 47K shares (+26%)
US Foods (USFD)
27K → 36K shares (+36%)
Shift4 (FOUR)
66K → 75K shares (+14%)
Icon (ICLR)
16K → 20K shares (+28%)
Krystal Biotech (KRYS)
4,904 → 9,034 shares (+84%)
Popular (BPOP)
14K → 19K shares (+32%)